SEMPREX D is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Endo Pharmaceuticals Inc.. The primary component is Acrivastine; Pseudoephedrine Hydrochloride.
Product ID | 52244-404_21d2a8a6-108c-4c1d-b1ee-c14f6f2dadc6 |
NDC | 52244-404 |
Product Type | Human Prescription Drug |
Proprietary Name | SEMPREX D |
Generic Name | Acrivastine And Pseudoephedrine Hydrochloride |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2012-01-26 |
Marketing End Date | 2020-12-31 |
Marketing Category | NDA / NDA |
Application Number | NDA019806 |
Labeler Name | Endo Pharmaceuticals Inc. |
Substance Name | ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE |
Active Ingredient Strength | 8 mg/1; mg/1 |
Pharm Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
NDC Exclude Flag | N |
Marketing Start Date | 2012-01-26 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA019806 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2012-01-26 |
Ingredient | Strength |
---|---|
ACRIVASTINE | 8 mg/1 |
SPL SET ID: | d86c6a13-9e5f-43c2-92f5-c7ed7bfcedfc |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SEMPREX 78429596 3023249 Live/Registered |
ACTIENT PHARMACEUTICALS LLC 2004-06-03 |
SEMPREX 74338456 1879087 Dead/Cancelled |
Burroughs Wellcome Co. 1992-12-09 |
SEMPREX 73514851 1421747 Live/Registered |
SEMPREX CORPORATION 1984-12-24 |